U.S. Autotransfusion Services Market by Size, Share, Trends, Growth, Segments till 2027
The U.S. autotransfusion services market is set to gain impetus from the increasing number of surgical procedures occurring in the country. It is, in turn, expected to surge the need for blood transfusion. This information is given by Fortune Business Insights™ in a new study, titled, “U.S. Autotransfusion Services Market Size, Share & COVID-19 Impact Analysis, By Indication (Cardiovascular, Orthopedic, Neurology, Gynecology, Urology, Trauma, and Others), By End User (Hospitals, and Ambulatory Surgery Centers), and Forecast, 2020-2027.” The study further mentions that the U.S. autotransfusion services market size was USD 838.4 million in 2019 and is projected to reach USD 1,072.1 million by 2027, exhibiting a CAGR of 6.5% during the forecast period.
For more information in the analysis of this report, visit:
https://www.fortunebusinessinsights.com/u-s-autotransfusion-services-market-104196
A list of all the renowned autotransfusion services providers operating in the U.S. market:
- Comprehensive Care Services (Michigan, U.S.)
- SpecialtyCare (Tennessee, U.S.)
- Keystone Perfusion (Pennsylvania, U.S.)
- Atlanta Surgical Services Inc. (Atlanta, U.S.)
- Vivacity Perfusion (Tennessee, U.S.)
- Carolina Autotransfusion, Inc. (South Carolina, U.S.)
- CENTRAL VALLEY PERFUSION, INC. (California, U.S.)
- Other Prominent Players
COVID-19 to Hamper Growth Backed by Cancellation of Various Procedures
The Minneapolis Heart Institute Foundation states that in the U.S., there was an estimated decline of 40% in ST-elevation myocardial infarction (STEMI) procedures during the first quarter of 2020. The COVID-19 pandemic is the major contributor to this loss because of the cancellation of surgeries, as well as low demand for autotransfusion services. Also, the rising number of strict laws implemented by the government of various countries is compelling people to remain at their homes to prevent transmission. Our high-quality reports would help you find the way towards success.
Segment-
Orthopedic Segment to Exhibit High CAGR Fueled by Presence of Multiple Companies
Based on indication, the orthopedic segment earned 15.8% in terms of the U.S. autotransfusion services market share in 2019. It is anticipated to exhibit a comparatively higher CAGR in the near future on account of the presence of several companies offering autotransfusion services in the country. At the same time, the rising cases of knee and hip replacement procedures would bolster growth of the segment.
Drivers & Restraints-
Increasing Beneficial Properties to Accelerate Demand
Autotransfusion services have numerous benefits. They are capable of removing pre-transfusion inspections related to allogeneic blood. At the same time, they can improve activities of coagulation factors, provide better oxygen transfer, and reduce the risk of infections. As per the Agency for Healthcare Research and Quality (AHRQ) and the American Academy of Orthopedic Surgeons (AAOS), every year, approximately 450,000 hip replacement and 790,000 knee replacement procedures are performed in the U.S. It is set to propel the U.S. autotransfusion services market growth in the coming years.
